Close Menu

NEW YORK (GenomeWeb) — Stemina Biomarker Discovery announced today that it has initiated a clinical study examining metabolism biomarkers for autism spectrum disorder (ASD) with the support of a $2.7 million grant from the National Institutes of Health.

Also funding the study is a $2.3 million investment from the Nancy Lurie Marks Family Foundation that Stemina received last year.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

President Donald Trump might not approve the stricter standards the US Food and Drug Administration is developing for authorizing a SARS-CoV-2 vaccine, according to Politico.

Wired reports that Oxitec has now developed a genetically modified fall armyworm.

A large genetic study finds SARS-CoV-2 viruses with a certain variant are spreading more than others, according to the Washington Post.

In Nature this week: sister-chromatid-sensitive chromosome conformation capture approach, and more.